Early to mid-stage biotech companies are finding today’s equity and debt markets increasingly unattractive or unavailable. As a result, many are turning to alternative sources of capital. Royalty monetizations have been surging and filling that gap, offering a creative and non-dilutive way to unlock funding.

Join Partners George Shuster, Nathan Moore, David Strong, and Counsel Jana Lama for a webinar exploring what makes royalty monetizations an appealing capital-raising tool, where they may fit best in a company’s lifecycle, and key legal and tax considerations for implementation in an evolving capital structure. 

*CLE credit is not available for those who watch a recording of the webinar.

WilmerHale has been accredited by the New York State and California State Continuing Legal Education Boards as a provider of continuing legal education. This program is being planned with the intention to offer CLE credit in California and non-transitional credit in New York for attendees who join the live presentation. This program, therefore, is being planned with the intention to offer CLE credit for experienced New York attorneys only. Attendees of this program may be able to claim England & Wales CPD. WilmerHale has been approved as a Colorado Certified Provider, as recognized by the Colorado Supreme Court Continuing Legal and Judicial Education Committee. We will apply for Colorado CLE (after the program) if requested. The type and amount of credit awarded will be determined solely by the Colorado Supreme Court. New Jersey grants reciprocal credit for programs that are approved in New York. We can also issue Connecticut credit. All attendees, regardless of jurisdiction, will receive a uniform certificate of attendance that shows the states in which the program was approved. Attendees who need credit in another jurisdiction can use the uniform certificate of attendance to self-apply. CLE credit is not available for on-demand webinar recordings.